The excitement of investing in a company that can turn its fate back is a big draw for some speculators, so even companies with no income or profit, and without shortage records can find investors. But the reality is that when a company loses money each year, its investors usually divide those losses for a long enough time. The company that adds losses has not yet proven profitable, and ultimately the inflow of external capital may dry up.
Therefore, if this high-risk and high-reward idea is not suitable, you may be more interested in profitable growth companies like Austco Healthcare (ASX: AHC). While this doesn't necessarily mean that it's underestimated, the profitability of the business is sufficient to guarantee some appreciation, especially if it's growing.
Check out the latest analysis from Austco Healthcare
Generally, companies experiencing earnings per share (EPS) growth should see similar trends in stock prices. This will make EPS growth attractive to any company. Certainly, it's great to see Austco Healthcare increase by 19% per year over three years. If this kind of growth continues in the future, shareholders will have a lot to smile.
Topline growth, coupled with growth being sustainable and high revenue before interest and taxation (EBIT) margins, is a great way for companies to maintain a competitive advantage in the market. The good news is that Austco Healthcare is increasing its revenue, with EBIT margins improving to 13%, an 8.9 percentage point improvement over last year. It's great to see on both counts.
You can see the company's revenue and revenue growth trends in the chart below. Click on the chart to see the exact numbers.
Austco Healthcare is not huge, but has a market capitalization of $100 million, so you definitely need to check your cash and debt before you get too excited about your prospects.
It's fun to see corporate leaders, so to speak, see them, as a result of increasing incentive integrity between the people running the business and their true owners. Shareholders are pleased with the fact that insiders amount to a substantial amount of Osco's healthcare stock. Certainly, they hold $27 million worth of shares. It shows significant buy-in and could indicate a conviction in business strategy. As a percentage, this is 27% of the stock on business issues, a significant amount taking into account market capitalization.
The story continues
